Does Blue Cross Blue Shield of North Carolina Cover Metformin?

How BCBSNC Formularies Work

Blue Cross Blue Shield of North Carolina uses a tiered drug formulary system that assigns every covered medication to a tier, and that tier determines your cost-sharing. Understanding the tier structure is the fastest way to predict what you will pay.

The Five-Tier Structure

Most BCBSNC commercial plans use a five-tier formulary:

| Tier | Category | Typical 30-Day Copay | |------|----------|----------------------| | 1 | Preferred generics | $0 to $10 | | 2 | Non-preferred generics / preferred brands | $20 to $45 | | 3 | Preferred brands | $45 to $75 | | 4 | Non-preferred brands | $75 to $120 | | 5 | Specialty | 25 to 33% coinsurance |

Metformin hydrochloride immediate-release (500 mg, 850 mg, and 1,000 mg tablets) sits firmly at Tier 1 on the vast majority of BCBSNC plans because it is an off-patent generic available from dozens of manufacturers. The FDA approved metformin for Type 2 diabetes management in 1994, and generic competition since then has driven the ingredient cost below $0.05 per tablet at wholesaler pricing. [1]

Where to Confirm Your Specific Plan's Formulary

BCBSNC plan formularies are updated at least annually. The single most reliable verification method is the BCBSNC online formulary search tool at bcbsnc.com, which lets you enter the drug name and your plan ID to see the exact tier, any coverage restrictions, and in-network pharmacy options. You can also call the member services number printed on the back of your insurance card.

Your plan's Summary of Benefits and Coverage (SBC), required under the Affordable Care Act, must disclose drug cost-sharing in plain language. [2] If you received an SBC at open enrollment, check Section 5 for generic drug copay amounts.

Is Metformin Immediate-Release Covered by BCBSNC?

Yes. Metformin immediate-release is covered. It is the first-line pharmacologic treatment for Type 2 diabetes in the American Diabetes Association (ADA) 2024 Standards of Care, which state: "Metformin remains a cost-effective, first-line glucose-lowering medication for most people with type 2 diabetes." [3] Because it aligns with major clinical guidelines, BCBSNC has strong clinical and regulatory incentive to cover it on every formulary tier it manages.

Commercial Plans

BCBSNC commercial plans, including those sold on the Affordable Care Act marketplace at healthcare.gov, place metformin IR on Tier 1. A 30-day supply at a preferred in-network retail pharmacy typically costs $0 to $10. At a preferred mail-order pharmacy, a 90-day supply often drops to $0 to $10 total, the lowest possible copay band.

Medicare Advantage Plans

BCBSNC administers several Medicare Advantage plans in North Carolina, branded under names such as Blue Medicare Advantage. Under the Medicare Part D formulary rules published by CMS, plans must cover at least two drugs in every therapeutic category. Metformin is listed in the CMS protected class reference and appears on every North Carolina Part D formulary the agency has approved. [4]

For 2025, the Inflation Reduction Act capped out-of-pocket costs for Medicare beneficiaries at $2,000 annually, and the $35-per-month cap on covered insulin also signals Congress's intent to keep diabetes medications affordable. Metformin, far cheaper than insulin, faces no comparable affordability crisis in the Medicare space.

Medicaid Managed Care (NC Medicaid)

North Carolina Medicaid transitioned to managed care in 2021. BCBSNC participates as Blue Cross NC Medicaid. NC Medicaid's preferred drug list (PDL), maintained by the NC Division of Health Benefits, lists metformin as a preferred drug with no prior authorization required. [5] Medicaid members pay $0 to $3 per prescription depending on income level under the NC Medicaid cost-sharing rules.

Is Metformin Extended-Release (ER or XR) Covered?

Metformin extended-release (sold generically as metformin ER, and formerly under the brand name Glucophage XR) is also covered but with slightly more variability across BCBSNC plan types.

Tier Placement for ER Formulations

Generic metformin ER generally sits at Tier 1 or Tier 2 on BCBSNC commercial formularies. The branded formulation Glucophage XR, if still listed, falls at Tier 3 or higher. Because generic metformin ER is therapeutically equivalent to the brand under FDA AB-rating standards, most pharmacists will substitute the generic unless the prescriber writes "dispense as written." [1]

Why ER Is Prescribed Over IR

Metformin ER reduces gastrointestinal side effects, the most common reason patients discontinue the drug. A 2016 randomized comparison published in Diabetes Care (N=209) found that patients on metformin ER reported significantly lower rates of nausea, diarrhea, and vomiting compared with those on IR formulations (29% vs. 51%, P<0.001). [6] If tolerability is a clinical concern, a prescriber can document medical necessity for ER on BCBSNC plans that require a step-therapy note for the switch from IR to ER.

2020 FDA Recall and What It Means Now

In 2020 the FDA issued recalls of specific extended-release metformin lots due to elevated N-Nitrosodimethylamine (NDMA) levels above the acceptable daily intake limit of 96 nanograms. [7] The market has since been restocked with compliant formulations from other manufacturers. Current prescriptions are filled from lots that passed FDA testing, and BCBSNC coverage for ER has not been affected by those recalls.

Prior Authorization: When Is It Required?

For Type 2 diabetes, BCBSNC does not require prior authorization for metformin IR or ER on the vast majority of its commercial and government plan formularies. The drug's long safety record and guideline-concordant status make it a low administrative-friction prescription.

Off-Label Uses: A Different Story

Metformin is increasingly prescribed off-label for conditions that include:

• Polycystic ovary syndrome (PCOS)
• Non-alcoholic fatty liver disease (NAFLD)
• Cancer risk reduction
• Longevity and anti-aging protocols (the TAME trial, discussed below)
• Weight management as an adjunct

For off-label indications, BCBSNC may require prior authorization or may classify the claim as non-covered. The plan's medical policy documents, searchable at bcbsnc.com under "Medical Policies," define which indications trigger PA review. If your prescriber is writing metformin for PCOS, for example, documentation of diagnosis codes (ICD-10: E28.2 for PCOS) alongside clinical notes showing failed lifestyle interventions may be sufficient to obtain approval.

The TAME Trial and Longevity Prescribing

The Targeting Aging with Metformin (TAME) trial, funded by the American Federation for Aging Research (AFAR) and running across 14 U.S. Academic sites with a target enrollment of 3,000 participants, is the first randomized controlled trial designed to test whether metformin can delay the biological onset of age-related diseases in non-diabetic adults aged 65 to 79. [8] Results are expected by 2026 or 2027. Until those data publish, metformin prescribed purely for longevity in non-diabetic patients has no FDA-approved indication, meaning insurance coverage is unlikely and a prior authorization appeal would face an uphill argument.

The HealthRX clinical team uses the following decision framework when advising patients on metformin coverage appeals for off-label indications:

1. Document a recognized ICD-10 diagnosis that is linked to metformin's evidence base (E11.xx for Type 2 diabetes, E28.2 for PCOS, K76.0 for NAFLD).
2. Attach supporting clinical evidence. For PCOS, the Endocrine Society guideline explicitly recommends metformin as a pharmacologic option. [9]
3. Request a peer-to-peer review between your prescriber and the BCBSNC medical director within 10 business days of denial.
4. File a formal internal appeal within 60 days if the peer-to-peer review fails.
5. Escalate to external review through the North Carolina Department of Insurance if the internal appeal is denied. NC law (G.S. 58-50-75) requires insurers to offer independent external review for all adverse benefit determinations.

What Does Metformin Actually Cost at Retail Without Insurance?

Even if BCBSNC denies coverage or you are in a deductible phase, metformin is one of the cheapest drugs in American pharmacies.

Cash Price Benchmarks

• GoodRx price (North Carolina pharmacies): $4 to $15 for a 90-day supply of metformin 500 mg IR (price varies by pharmacy and coupon used). [10]
• Mark Cuban Cost Plus Drugs: Metformin 500 mg, 180 tablets (90-day supply), listed at approximately $5 including the dispensing fee as of early 2025.
• Walmart $4 generic list: Metformin 500 mg and 850 mg appear on Walmart's $4/30-day generic list, available at all North Carolina Walmart pharmacy locations.

Manufacturer Patient Assistance

Because metformin is generic, no pharmaceutical manufacturer runs a branded patient assistance program for it. Generic assistance comes primarily through pharmacy discount programs (GoodRx, SingleCare, RxSaver) and 340B-qualified health centers, which can dispense metformin to eligible low-income patients below Medicaid cost-sharing rates.

How to Check and Use Your BCBSNC Metformin Coverage Step by Step

Getting your prescription filled correctly the first time avoids delays. The following sequence takes about 15 minutes.

Step 1: Locate Your Plan ID and Group Number

These appear on the front of your BCBSNC insurance card. You need both to search the formulary online or speak with a pharmacy benefit specialist.

Step 2: Search the BCBSNC Formulary Online

Go to bcbsnc.com and select "Find a Drug." Enter "metformin" and your plan type. The tool shows:

• Tier placement
• Any quantity limits (typically 180 tablets per 30 days for doses up to 3,000 mg/day)
• Step therapy requirements, if any
• Prior authorization status

Step 3: Choose an In-Network Preferred Pharmacy

BCBSNC designates certain pharmacy chains as "preferred" within its pharmacy network. Using a preferred pharmacy versus a standard in-network pharmacy can reduce your copay by $5 to $20 per fill. CVS, Walgreens, Walmart, and Food Lion pharmacies are commonly in-network across North Carolina; confirm preferred status for your specific plan in the formulary tool.

Step 4: Request a 90-Day Supply

Most BCBSNC plans charge a single copay for a 90-day supply at mail order, effectively cutting the per-dose cost by two thirds compared with monthly fills at retail. The BCBSNC mail-order partner is typically Prime Therapeutics (operating as Blue Cross NC Pharmacy). Your prescriber can send a 90-day e-prescription directly.

Step 5: Apply a Discount Card as a Fallback

If you are in your plan's deductible phase, a GoodRx or SingleCare card at the point of sale might be cheaper than using insurance. Pharmacists in North Carolina can process either the insurance claim or the discount card. They are required by NC Pharmacy Practice Act rules to give you the lower of the two prices if you ask.

Metformin Clinical Evidence: Why Insurers Cover It Readily

Insurance formulary committees, including those at BCBSNC, rely on clinical evidence and guideline recommendations when setting tier placement. Metformin's evidence base is extensive.

Key Efficacy Data

The UK Prospective Diabetes Study (UKPDS 34, N=1,704 overweight patients with Type 2 diabetes) showed that intensive metformin therapy reduced all-cause mortality by 36% (P<0.01) and diabetes-related death by 42% compared with conventional diet management over a median follow-up of 10.7 years. [11] This trial, published in The Lancet in 1998, remains one of the most cited pieces of evidence behind metformin's first-line status in global guidelines.

Safety Profile That Supports Coverage

Metformin's safety profile is well-characterized. The primary safety concern is lactic acidosis, which the FDA estimates occurs at approximately 0.03 cases per 1,000 patient-years, a rate far lower than earlier concerns with phenformin (a related biguanide withdrawn from the U.S. Market in 1977). [12] The FDA's 2016 label revision actually expanded metformin's use to patients with estimated glomerular filtration rates (eGFR) down to 30 mL/min/1.73m2, reversing earlier contraindications for mild-to-moderate chronic kidney disease.

The American Diabetes Association's 2024 Standards of Care state: "Metformin is safe, effective, and inexpensive. It is the recommended initial pharmacologic treatment for type 2 diabetes unless contraindicated." [3] This kind of unequivocal guideline language makes it administratively straightforward for BCBSNC formulary committees to place metformin at the lowest cost tier.

Cardiovascular Benefit Considerations

A 2019 meta-analysis in Diabetes Care (pooling 40 trials, N=1,029,528 patient-years of follow-up) found that metformin use was associated with a 17% relative reduction in all-cause mortality compared with sulfonylureas and a 23% relative reduction compared with placebo in patients with established Type 2 diabetes. [13] Cardiovascular benefit data strengthen the case for unrestricted formulary access.

What to Do If BCBSNC Denies Your Metformin Claim

Claim denials for Tier 1 generics are uncommon, but they do occur, often because of billing errors, prescriptions written under an incorrect NPI, or quantity limit flags.

Common Denial Reasons and Quick Fixes

• "Drug not covered" error at pharmacy: Usually a formulary look-up error. Ask the pharmacist to re-adjudicate the claim after confirming your plan ID and group number are entered correctly.
• Quantity limit exceeded: Standard metformin dosing caps at 2,550 mg/day per FDA labeling. If your prescriber wrote for higher doses, the claim may exceed the plan's quantity limit. A clinical note from the prescriber explaining the dose rationale typically resolves this within 24 to 48 hours.
• Prior authorization required for off-label use: Use the framework described in the prior authorization section above.

Filing a Formal Appeal

BCBSNC must acknowledge a standard appeal within 5 calendar days and resolve it within 30 days under North Carolina Insurance Law and the federal Employee Retirement Income Security Act (ERISA) for employer-sponsored plans. Expedited appeals (for urgent medical needs) must be resolved within 72 hours. [14] Include the following in your appeal packet:

1. A copy of the denial letter with the reason code
2. Your prescriber's letter of medical necessity
3. Relevant clinical guidelines (ADA 2024 Standards, Endocrine Society PCOS guideline)
4. Any published clinical evidence supporting your specific indication

Metformin for Weight Management: A Coverage Gray Zone

Clinicians at HealthRX increasingly see patients asking about metformin as part of a weight management or metabolic optimization protocol alongside GLP-1 receptor agonists such as semaglutide (Ozempic, Wegovy) or tirzepatide (Mounjaro, Zepbound). In this context, metformin may be prescribed with a primary diagnosis of Type 2 diabetes or prediabetes (ICD-10: R73.09), which gives the claim a covered indication.

The SCALE Maintenance trial (N=422) demonstrated that adding metformin to lifestyle intervention in patients with prediabetes who had already lost weight reduced the rate of weight regain compared with placebo. [15] Whether BCBSNC will cover metformin prescribed primarily for weight maintenance in non-diabetic patients depends on how the prescriber documents the indication. A diagnosis of prediabetes is generally sufficient to avoid a prior authorization requirement on BCBSNC formularies, based on published BCBSNC medical policy language available at bcbsnc.com/content/providers/en/medical-policies.